Home Bancshares Inc.
Congress has disclosed 3 buys and 4 sells of HOMB (Home Bancshares Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
9 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Lisa McClain | House | SELL | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-31 | 1 days | 0.0% | $1K–$15K 0.1% of NW |
7.8 | ↗ filing |
| Lisa McClain | House | BUY | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-30 | 2 days | -0.0% | $1K–$15K 0.1% of NW |
28.1 | ↗ filing |
| Lisa McClain | House | SELL | Spouse · Charles Schwab Brokerage Account 924 | 2025-10-30 | 2 days | -0.0% | $1K–$15K 0.1% of NW |
28.1 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence · moderate | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-17 | 57 days | +5.8% | $1K–$15K 0.1% of NW |
63.6 | ↗ filing |
| Jefferson Shreve | House | SELL ◆ insider convergence · moderate | Self · CRT - Standard Unit Trust | 2025-05-12 | 3 days | 0.0% | $15K–$50K <0.1% of NW |
28.6 | ↗ filing |
| Jefferson Shreve | House | BUY ◆ insider divergence | Self · CRT - Standard Unit Trust | 2025-04-07 | 18 days | +10.2% | $15K–$50K <0.1% of NW |
48.6 | ↗ filing |
| Jefferson Shreve | House | SELL ◆ insider divergence · strong | Self · CRT - Standard Unit Trust | 2025-03-05 | 23 days | -2.7% | $15K–$50K <0.1% of NW |
69.2 | ↗ filing |
| Debbie Wasserman Schultz | House | EXCHANGE | Joint | 2017-09-26 | 16 days | — | $1K–$15K | 75.9 | ↗ filing |
| Debbie Wasserman Schultz | House | EXCHANGE | Self | 2017-09-26 | 16 days | — | $15K–$50K | 90.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in HOMB — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in HOMB, 1 coincided with corporate insiders moving the same way within 60 days, and 3 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-10-29 | Allison John W II | Director | SELL | $406K | ↗ EDGAR |
| 2026-08-11 | Rankin Jim | Director | SELL | $463K | ↗ EDGAR |
| 2026-08-04 | TIPTON JOHN STEPHEN | C-suite | SELL | $379K | ↗ EDGAR |
| 2026-06-01 | Allison John W II | Director | SELL | $53K | ↗ EDGAR |
| 2026-04-21 | FLOYD JENNIFER C. | C-suite | SELL | $81K | ↗ EDGAR |
| 2026-04-17 | ALLISON JOHN W | C-suite | BUY | $2.7M | ↗ EDGAR |
| 2026-02-23 | Allison John W II | Director | SELL | $141K | ↗ EDGAR |
| 2026-02-11 | Hinkle James G | Director | SELL | $908K | ↗ EDGAR |
| 2026-01-28 | Townsell Donna | Director | SELL | $158K | ↗ EDGAR |
| 2025-08-26 | ALLISON JOHN W | C-suite | SELL | $3.3M | ↗ EDGAR |
| 2025-06-20 | TIPTON JOHN STEPHEN | C-suite | SELL | $665K | ↗ EDGAR |
| 2025-05-09 | Hester Kevin | C-suite | SELL | $189K | ↗ EDGAR |
| 2025-05-08 | Hester Kevin | C-suite | SELL | $204K | ↗ EDGAR |
| 2025-04-23 | FLOYD JENNIFER C. | C-suite | SELL | $69K | ↗ EDGAR |
| 2025-01-21 | ALLISON JOHN W | C-suite | BUY | $308K | ↗ EDGAR |
| 2024-11-25 | LIEBLONG ALEX R | Director | SELL | $1.8M | ↗ EDGAR |
| 2024-11-18 | Hickman James Pat | Director | SELL | $31K | ↗ EDGAR |
| 2024-11-18 | Hickman James Pat | Director | SELL | $462K | ↗ EDGAR |
| 2024-11-18 | Hickman James Pat | Director | SELL | $617K | ↗ EDGAR |
| 2024-11-18 | Hickman James Pat | Director | SELL | $862K | ↗ EDGAR |
| 2024-11-18 | Hickman James Pat | Director | SELL | $1.1M | ↗ EDGAR |
| 2024-11-07 | FLOYD JENNIFER C. | C-suite | SELL | $60K | ↗ EDGAR |
| 2024-11-06 | Engelkes Jack | Director | SELL | $753K | ↗ EDGAR |
| 2024-07-19 | Hester Kevin | C-suite | SELL | $682K | ↗ EDGAR |
| 2024-07-19 | Davis Brian | C-suite | SELL | $414K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-10-29 | Allison John W II Director | SELL | $406K |
| ◆ insider | 2026-08-11 | Rankin Jim Director | SELL | $463K |
| ◆ insider | 2026-08-04 | TIPTON JOHN STEPHEN C-suite | SELL | $379K |
| ◆ insider | 2026-06-01 | Allison John W II Director | SELL | $53K |
| ◆ insider | 2026-04-21 | FLOYD JENNIFER C. C-suite | SELL | $81K |
| ◆ insider | 2026-04-17 | ALLISON JOHN W C-suite | BUY | $2.7M |
| ◆ insider | 2026-02-23 | Allison John W II Director | SELL | $141K |
| ◆ insider | 2026-02-11 | Hinkle James G Director | SELL | $908K |
| ◆ insider | 2026-01-28 | Townsell Donna Director | SELL | $158K |
| Congress | 2025-10-31 | Lisa McClain | SELL | $1K–$15K |
| Congress | 2025-10-30 | Lisa McClain | BUY | $1K–$15K |
| Congress | 2025-10-30 | Lisa McClain | SELL | $1K–$15K |
| ◆ insider | 2025-08-26 | ALLISON JOHN W C-suite | SELL | $3.3M |
| ◆ insider | 2025-06-20 | TIPTON JOHN STEPHEN C-suite | SELL | $665K |
| Congress | 2025-06-17 | Lisa McClain | BUY | $1K–$15K |
| Congress | 2025-05-12 | Jefferson Shreve | SELL | $15K–$50K |
| ◆ insider | 2025-05-09 | Hester Kevin C-suite | SELL | $189K |
| ◆ insider | 2025-05-08 | Hester Kevin C-suite | SELL | $204K |
| ◆ insider | 2025-04-23 | FLOYD JENNIFER C. C-suite | SELL | $69K |
| Congress | 2025-04-07 | Jefferson Shreve | BUY | $15K–$50K |
| Congress | 2025-03-05 | Jefferson Shreve | SELL | $15K–$50K |
| ◆ insider | 2025-01-21 | ALLISON JOHN W C-suite | BUY | $308K |
| ◆ insider | 2024-11-25 | LIEBLONG ALEX R Director | SELL | $1.8M |
| ◆ insider | 2024-11-18 | Hickman James Pat Director | SELL | $31K |
FAQ Common questions
How much has Congress traded HOMB?
3 disclosed buys and 4 sells of HOMB (Home Bancshares Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade HOMB?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.